Englewood, NJ, United States of America

George Aaron

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Other. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: George Aaron. Retrieved from https://idiyas.com/inventor/george-aaron

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal1 out of 834,601 
Other
 patents

Years Active: 2007

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: George Aaron - Innovator in Immunoassays

Introduction

George Aaron is a notable inventor based in Englewood, NJ (US). He has made significant contributions to the field of immunoassays, particularly in the detection of everolimus. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.

Latest Patents

George Aaron holds 1 patent for his invention titled "Immunoassays for everolimus." This patent provides methods for the detection of everolimus, along with compounds for producing antibodies specific to this drug. The antibodies produced from these compounds are also included in the patent, highlighting the innovative approach taken by Aaron in this area.

Career Highlights

Throughout his career, George Aaron has worked with various companies, including Seradyn, Inc. His experience in the industry has allowed him to develop and refine his inventions, contributing to advancements in immunoassay technology.

Collaborations

George has collaborated with notable individuals in his field, including Mark F. Roberts and Lili Arabshahi. These collaborations have likely enriched his work and expanded the impact of his inventions.

Conclusion

George Aaron's contributions to immunoassays demonstrate the vital role of inventors in advancing medical technology. His innovative work continues to influence the detection and application of everolimus in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…